THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 2 filers reported holding THERAVANCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $15,462,000 | -27.7% | 16,980,000 | -24.5% | 0.18% | -29.8% |
| Q1 2017 | $21,398,000 | -44.2% | 22,480,000 | -51.4% | 0.25% | -49.6% |
| Q4 2016 | $38,371,000 | -5.4% | 46,230,000 | -4.1% | 0.50% | -13.2% |
| Q3 2016 | $40,542,000 | +4.2% | 48,230,000 | 0.0% | 0.58% | +9.1% |
| Q2 2016 | $38,926,000 | +3.1% | 48,230,000 | 0.0% | 0.53% | -3.1% |
| Q1 2016 | $37,770,000 | +4.8% | 48,230,000 | 0.0% | 0.54% | -16.7% |
| Q4 2015 | $36,052,000 | +14.1% | 48,230,000 | 0.0% | 0.65% | +24.3% |
| Q3 2015 | $31,591,000 | -30.6% | 48,230,000 | 0.0% | 0.53% | -30.7% |
| Q2 2015 | $45,517,000 | +10.4% | 48,230,000 | 0.0% | 0.76% | +9.5% |
| Q1 2015 | $41,237,000 | +31.2% | 48,230,000 | +20.3% | 0.69% | +12.3% |
| Q4 2014 | $31,420,000 | +91.5% | 40,089,000 | +134.6% | 0.62% | +115.7% |
| Q3 2014 | $16,405,000 | – | 17,089,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $1 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |